Functional gene set enrichment analysis and siRNA knockdown of several candidate genes revealed a set of homeobox transcription factors (specifically MEOX1) as novel potential targets in the PTEN-deficient trastuzumab-resistant breast cancer cells. This evidence concerns the gene PTEN and breast carcinoma.